GlassScriptPhysician profile
Shashidhar Kusuma
NPI 1598770430
$4,618.56
in general payments reported to CMS, 2019-2025
16 companies · $1,008 in 2025
The $1,008 reported for 2025 was more than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $558 · 2021: $1,751 · 2022: $151 · 2023: $13.97 · 2024: $1,138 · 2025: $1,008.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,878 · Long Term Medical Supply Or Device Loan: $282.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,877.69 |
| Long Term Medical Supply Or Device Loan | $281.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $1,859.93 | 2019-2022 | |
| Integra Lifesciences Corporation | $404.40 | 2024 | Integra, Acell, Integra Dermal Regeneration Template |
| Musculoskeletal Transplant Foundation INC. | $368.25 | 2022-2025 | |
| Sientra, INC. | $360.24 | 2019-2022 | |
| Abbvie INC. | $343.61 | 2024-2025 | |
| Motiva USA, LLC | $229.21 | 2025 | |
| Revance Therapeutics, INC. | $153.93 | 2025 | Daxxify |
| Kerecis Limited | $145.59 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Polynovo North America LLC | $140.38 | 2024 | Novosorb Btm |
| Rti Surgical, INC | $123.53 | 2024 | |
| Stryker Corporation | $122.55 | 2024 | 1788 |
| Coopersurgical, INC. | $96.01 | 2019 | |
| Eagle Pharmaceuticals, INC. | $79.66 | 2019 | |
| Mentor Worldwide LLC | $74.76 | 2019-2024 | Mentor Memorygel Resterilizable Gel Sizer |
| Tela Bio, INC. | $67.25 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $49.26 | 2023-2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shashidhar Kusuma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.